Predicting success in phase III studies from phase II results: a new paradigm is needed

J Clin Oncol. 2008 Jul 20;26(21):3653-4; author reply 3654-5. doi: 10.1200/JCO.2008.17.5000.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials, Phase II as Topic*
  • Clinical Trials, Phase III as Topic
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents